Aurobindo Pharma Ltd AUROPHARMA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 1,177.60
- Day Range
- INR 1,155.00–1,190.20
- 52-Week Range
- INR 581.25–1,190.00
- Bid/Ask
- INR 1,160.30 / INR 1,160.70
- Market Cap
- INR 680.16 Bil
- Volume/Avg
- 533,482 / 1.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- 23.54
- Price/Sales
- 2.50
- Dividend Yield (Trailing)
- 0.38%
- Dividend Yield (Forward)
- 0.38%
- Total Yield
- 0.38%
Company Profile
Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. The company's product portfolio spans a variety of therapeutic areas. The vast majority of the company's sales are generated in the United States, followed by Europe. Most of Aurobindo's sales are derived from its formulations business, with the rest stemming from its active pharmaceutical ingredient operations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 15,690
- Website
- https://www.aurobindo.com
Comparables
Valuation
|
Metric
|
AUROPHARMA
|
532300
|
533573
|
|---|---|---|---|
Price/Earnings (Normalized) | 23.54 | — | 32.09 |
Price/Book Value | 2.45 | 2.48 | 3.89 |
Price/Sales | 2.50 | 2.80 | 3.01 |
Price/Cash Flow | 18.74 | — | 22.04 |
Price/Earnings
AUROPHARMA
532300
533573
Financial Strength
|
Metric
|
AUROPHARMA
|
532300
|
533573
|
|---|---|---|---|
Quick Ratio | 0.93 | 0.31 | 0.83 |
Current Ratio | 1.81 | 0.76 | 2.12 |
Interest Coverage | 16.28 | −0.47 | 12.24 |
Quick Ratio
AUROPHARMA
532300
533573
Profitability
|
Metric
|
AUROPHARMA
|
532300
|
533573
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
AUROPHARMA
532300
533573
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Wbhqplpkd | Rvwsl | $77.1 Bil | |
MKKGY
| Merck KGaA ADR | Ljrhvsxxm | Vgztmn | $72.9 Bil | |
HLN
| Haleon PLC ADR | Myknhfpd | Kzcp | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Dhclkrmrm | Zcgw | $18.3 Bil | |
VTRS
| Viatris Inc | Gtcswzby | Wtwff | $13.5 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Fcnfdcdvt | Rph | $11.7 Bil | |
CTLT
| Catalent Inc | Qmyjmmdc | Vrblv | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Tdxbbkbg | Wnh | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Ksqvlhrc | Ydr | $4.2 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Fxdwyzv | Zkzvkz | $3.5 Bil |